Login / Signup

Symptom and Treatment Satisfaction in Members of the US and Canadian GBS/CIDP Foundations with a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy.

Meg MendozaChristopher TranVera BrilHans D KatzbergCarolina Barnett-Tapia
Published in: Advances in therapy (2023)
A high proportion of members of the US and Canadian GBS/CIDP Foundations reporting a diagnosis of CIDP were unsatisfied with current symptoms, despite a high level of overall satisfaction with treatments. There is an unmet need for improving long-term outcomes in people with a diagnosis of CIDP, and for studying patient-centered long-term treatment goals.
Keyphrases
  • oxidative stress
  • emergency department
  • public health
  • depressive symptoms
  • replacement therapy
  • adverse drug
  • global health